This scientific statement from the American Heart Association focuses on treatment
strategies and modalities for cardiomyopathy (heart muscle disease) in children and serves …

Background Previous studies have demonstrated that children in the United States who
were of racial and ethnic minorities have inferior waitlist and post-heart transplant (HT) …

Hypertrophic cardiomyopathy (HCM) is a primary heart muscle disease characterized by left
ventricular hypertrophy that can be asymptomatic or with presentations that vary from left …

Background To date, no studies evaluated implicit bias among clinicians caring for children
with advanced heart failure. Objectives This study aims to evaluate implicit racial and …

Background We evaluated the impact of pediatric heart-allocation policy changes over time
and the approval of the Berlin ventricular assist device (VAD) on waitlist (WL) outcomes for …

Background To date, no studies have identified an optimal metric to match donor-recipient
(DR) pairs in pediatric heart transplantation (HT). Objectives This study sought to identify …

Background Studies on readmission for pediatric heart failure (HF) patients is sparse.
Objectives This study evaluated 30-and 60-day readmission rates in pediatric HF patients …

BACKGROUND There is limited and conflicting information on waitlist and transplant
outcomes for children with myocarditis. METHODS Retrospective review included children …

Background Restrictive cardiomyopathy is amongst the least common forms of
cardiomyopathy in children. It results in diastolic heart failure with preserved systolic function …

Background To date, no study has evaluated the effects of low center performance
evaluations (CPE) on pediatric heart transplant center behavior. We sought to assess the …